When treating BPH-afflicted men's prostate glands, urinary catheters are most frequently used. According to the American Academy of Family Physicians (AAFP), 250,000 BPH procedures will be performed in the United States in 2022, along with about 2 million office visits. This disorder is also linked to pregnancy and may also result from harm or injury to the urethra, penis, or bladder. Urinary catheter use in prostate gland surgery, which accounts for around 37% of total revenue, is still the most lucrative segment of the Urinary Catheters Market. Urinary incontinence, which is acknowledged to be an underdiagnosed and treatable illness, is second.
To address the rising demand for these kinds of products from physicians, important businesses are also moving closer to producing indwelling or Foley catheters coated with teflon, silicon elastomer, and antimicrobial adhesive agents. By launching enhanced urinary catheter products and creating innovative technologies through continual investment in research and development operations, key players are concentrating on expanding their existing Urinary Catheters Market portfolio. Businesses are spending money on research and development projects to create biocompatible urinary catheters. Due to its resistance to chemicals and insensitivity to temperature fluctuations, silicone is increasingly used in the development of urinary catheters. Silicone-made urinary catheters also lower the risk of meatitis, urethritis, and trigonitis.
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2023/02/the-rising-prevalence-of-urinary.html
